Skip to main content

Table 4 Combination Index Values of AML cell lines and AML patients

From: Inhibition of CPT1a as a prognostic marker can synergistically enhance the antileukemic activity of ABT199

AML cell lines

Combination index values

ED50

ED75

ED90

THP-1

0.26890

0.24955

0.23277

Kasumi-1

0.25727

0.32034

0.87657

MV4-11

0.84190

0.51618

0.39560

OCI-AML2

0.63777

0.23040

0.27239

HL-60

0.48821

0.32436

0.21859

Patient

Combination index values

  

ED50

ED75

ED90

AML#1

0.67927

0.36933

0.23918

AML#2

0.94233

0.60820

0.55849

AML#3

1.39321

0.18723

0.18043

AML#4

2.26997

0.68618

0.29174

AML#5

0.18060

0.02656

0.00498

AML#6

0.88419

0.91904

0.96458

AML#7

0.41894

0.41487

0.60241

AML#8

0.33128

0.31352

0.35354

  1. ED50: 50% effective dose; ED75: 75% effective dose; ED90: 90% effective dose